Showing results (51-60 of 223) with videos related to

Sort By:
Pageof 23
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2019
Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in uteroAndrew L Smith, Jeffrey A Cohen, Daniel Ontaneda, et al.
The Lancet. Neurology|January 22, 2019
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disordersOlga Ciccarelli, Jeffrey A Cohen, Stephen C Reingold, et al.
Brain : a Journal of Neurology|October 21, 2017
Cell-based therapeutic strategies for multiple sclerosisNeil J Scolding, Marcelo Pasquini, Stephen C Reingold, et al.
Cleveland Clinic Journal of Medicine|February 1, 2006
Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying diseaseRobert J Fox, Francois Bethoux, Myla D Goldman, et al.
Lancet (London, England)|November 28, 2016
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of functionDaniel Ontaneda, Alan J Thompson, Robert J Fox, et al.
Therapeutics and Clinical Risk Management|October 31, 2017
Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development ProgramEva Havrdova, Jeffrey A Cohen, Dana Horakova, et al.
Therapeutic Advances in Neurological Disorders|October 11, 2019
Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study resultsJeffrey A Cohen, Nadia Tenenbaum, Alit Bhatt, et al.
Case Reports in Neurological Medicine|February 24, 2015
Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab TiuxetanMichael A Lane, Vijay Renga, Andrew R Pachner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2003
Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosisRuth Ann Marrie, Deborah M Miller, Gordon J Chelune, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2012
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection techniqueDevon S Conway, Deborah M Miller, Ralph G O'Brien, et al.
Pageof 23